Literature DB >> 10946315

The autoantibodies to alpha 6 beta 4 integrin of patients affected by ocular cicatricial pemphigoid recognize predominantly epitopes within the large cytoplasmic domain of human beta 4.

K C Bhol1, M J Dans, R K Simmons, C S Foster, F G Giancotti, A R Ahmed.   

Abstract

This study was undertaken to characterize the antigenic determinants recognized by the autoantibodies of patients with ocular cicatricial pemphigoid (OCP). OCP is a subepithelial, blistering, autoimmune disease that mainly affects the conjunctiva and other mucous membranes. We previously demonstrated that a cDNA clone, isolated from a keratinocyte expression library by using immunoaffinity-purified OCP autoantibody, encoded the cytoplasmic domain of beta 4 integrin subunit. Our subsequent studies showed that sera from all the OCP patients that were tested recognize the human beta 4 integrin subunit. To identify the prevalent epitopes of the anti-beta 4 autoantibodies of OCP, we have used cell lines transfected with vectors encoding a wild-type beta 4 subunit, a tailless beta 4 subunit, or a beta 4 subunit lacking the extracellular domain. Nontransfected cell lines were used as controls. Lysates from these cell lines were analyzed with OCP sera, IgG fractions from OCP sera, and immunoaffinity-purified OCP autoantibodies. Abs to extracellular and cytoplasmic domains of human beta 4 integrin were used as positive controls, whereas normal human sera and normal human IgG fractions were used as negative controls. The reactivity of OCP Abs was determined by using immunoblotting, immunoprecipitation, and FACS analysis. The results of this study indicate that OCP sera, OCP IgG fractions, and immunoaffinity-purified OCP autoantibodies react with the intracellular and not the extracellular domain of human beta 4 integrin subunit. In vitro cell culture experiments demonstrated that OCP autoantibody binds to the cytoplasm of the cells. The relevance of these findings to the pathogenesis of OCP is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10946315     DOI: 10.4049/jimmunol.165.5.2824

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously.

Authors:  L R Zakka; D B Keskin; P Reche; A R Ahmed
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

2.  Mucous membranepemphigoid in two half-sisters. The potential roles of autoantibodies to β4 integrin subunits and HLA-DQβ1*0301.

Authors:  Diogo Fabris Rabelo; Tegan Nguyen; Brooke Ann Caufield; Abdul Razzaque Ahmed
Journal:  J Dermatol Case Rep       Date:  2014-03-31

3.  Treatment of oral pemphigoid with intravenous immunoglobulin as monotherapy. Long-term follow-up: influence of treatment on antibody titres to human alpha6 integrin.

Authors:  N Sami; K C Bhol; A R Ahmed
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

4.  Tofacitinib for refractory ocular mucous membrane pemphigoid.

Authors:  Hayley James; Grace L Paley; Richard Brasington; Philip L Custer; Todd P Margolis; Michael A Paley
Journal:  Am J Ophthalmol Case Rep       Date:  2021-04-21

5.  Long-Term Follow-Up after Intravenous Immunoglobulin Therapy in Patients with Severe Ocular Mucous Membrane Pemphigoid Unresponsive to Conventional Therapy.

Authors:  Stefania Leuci; Massimo Amato; Elena Calabria; Raffaele Piscopo; Fausto Tranfa; Gianrico Spagnuolo; Michele Davide Mignogna
Journal:  J Ophthalmol       Date:  2018-09-19       Impact factor: 1.909

Review 6.  The Diagnosis and Blistering Mechanisms of Mucous Membrane Pemphigoid.

Authors:  Mayumi Kamaguchi; Hiroaki Iwata
Journal:  Front Immunol       Date:  2019-01-24       Impact factor: 7.561

Review 7.  Role of immune cells in the ocular manifestations of pemphigoid diseases.

Authors:  Tanima Bose
Journal:  Ther Adv Ophthalmol       Date:  2019-08-08

Review 8.  [Mucous membrane pemphigoid with ocular involvement. Part I: Clinical manifestations, pathogenesis and diagnosis].

Authors:  E Schmidt; T Meyer-Ter-Vehn; D Zillikens; G Geerling
Journal:  Ophthalmologe       Date:  2008-03       Impact factor: 1.174

9.  Expression of selected integrins and selectins in bullous pemphigoid.

Authors:  Agnieszka Zebrowska; Anna Sysa-Jedrzejowska; Małgorzata Wagrowska-Danilewicz; Ewa Joss-Wichman; Anna Erkiert-Polguj; Elzbieta Waszczykowska
Journal:  Mediators Inflamm       Date:  2007-04-02       Impact factor: 4.711

Review 10.  Molecular diagnosis in autoimmune skin blistering conditions.

Authors:  J V Otten; T Hashimoto; M Hertl; A S Payne; C Sitaru
Journal:  Curr Mol Med       Date:  2014-01       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.